Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started
Sign up to stay up to date with the stocks you care about
Follow Greater Cannabis Company, Inc.

Get SEC filing alerts via email and in your feed for Greater Cannabis Company, Inc.

GCAN

Greater Cannabis Company, Inc.

About Greater Cannabis Company, Inc.

The Greater Cannabis Company develops and commercializes cannabinoid therapeutics, focusing on innovative drug delivery platforms and neuropsychiatric treatments. It holds licenses for cannabinoid-based therapies targeting conditions like autism and Parkinson’s disease. The company operates in the medical cannabis sector, emphasizing research, clinical development, and strategic partnerships, with a business model centered on developing proprietary therapeutics and licensing technologies in a highly regulated industry.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Greater Cannabis Company, Inc.

1
1
2
1
3
1
4
1
5
1
6
1
7
1